Project Details
Description
A Phase 1/2, Multi-Center, Dose-Escalating Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Quizartinib Administered in Combination with Re-Induction Chemotherapy, and as a Single-Agent Maintenance Therapy, in Pediatric R
| Status | Active |
|---|---|
| Effective start/end date | 10/23/19 → 10/25/25 |
Funding
- THE CHILDREN'S HOSPITAL OF PHILADELPHIA
- DAIICHI SANKYO, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.